期刊文献+

间接胆红素在血浆置换联合山莨菪碱治疗血栓性血小板减少性紫癜中的变化观察 被引量:1

The observation the change of indirect bilirubin on plasma exchange combined with anisodamine in treatment of thrombotic thrombocytopenic purpura
下载PDF
导出
摘要 目的观察间接胆红素(I-Bil)在山莨菪碱加血浆置换(PE)干预血栓性血小板减少性紫癜(TTP)的变化情况,以了解山莨菪碱在TTP干预中的效果。方法选择82例TTP患者随机分组,联合干预组41例予山莨菪碱加血浆置换(PE),疗程21d;对照组41例单纯予以PE干预,疗程21d。结果联合干预组21d后有效率90.2%,对照组有效率82.9%,差异有显著性(P<0.05),I-Bil在干预后第2、5、12d数值下降速度明显快于对照组,差异有显著性(P<0.05),有统计学意义。结论血浆置换联合山莨菪碱注射液干预血栓性血小板减少性紫癜间接胆红素下降更快,疗效更好。 Objective To investigate the clinic efficacy and the change of indirect bilirubin on plasma exchange(PE) combined with anisodamine in the treatment of thrombotic thrombocytopenic purpura(TTP).Methods 82 patients were randomized into two groups,each group contained 41patients,the treatment group is given anisodamine injection combined with plasma exchange(PE),and the period of treatment is 21 days;the controlled group is just given plasma exchange and the period is also 21 days.Results The efficacy of the combined treatment group for 21 days is 90.2%,the controlled group is 82.9%,there were significant difference between tow groups(P0.05).The indirect bilirubin descend faster after treatment for 2,5 and 12 days than the controlled group,there were significant difference(P0.05),and there is statistic meaning.Conclusion Anisodamine combined with plasma exchange shows better clinic effect and the indirect bilirubin descend faster than plasma exchange alone in therapy of thrombotic thrombocytopenic purpura.
出处 《中国实验诊断学》 2013年第6期1017-1019,共3页 Chinese Journal of Laboratory Diagnosis
基金 唐山市科学技术研究与发展计划项目(05134608a)
关键词 间接胆红素 血栓性血小板减少性紫癜 血浆置换 山莨菪碱 Indirect bilirubin Thrombotic thrombocytopenic purpura Therapeutic plasma exchange Anisodamine
  • 相关文献

参考文献6

  • 1Sadler JE. Von Willebrandfactor, Adamts 13, and thrombotic Thrombocytopenic purpura[J]. Blood, 2008,112 (1) : 11.
  • 2Moake JL, Rudy CK, Troll JH, et al. Unusually large plasmafactor Ⅷ:vonWillebrand factormultimers in chronic relapsing throm boric thrombocytopenic purpura [J]. N Engl J Med, 1982,307:1432.
  • 3Furlan M, Robles R,LA Mie B, et al. Partia 1 purification andchar acterization of a protease from human plasma cleaving yon Wille brand factor to fragments produced by invivo proteolysis[J]. Blood,1996,87(10) :4223.
  • 4Murrin RJ, Murray JA. Thrombocytopenic purpura: aetiology, pathophysiology andtreatment[J]. Blood Rev, 2006,20 : 51.
  • 5郑昌成,吴竞生.血栓性血小板减少性紫癜的诊治现状与进展[J].中华血液学杂志,2011,32(9):645-648. 被引量:27
  • 6汪明性.药理学[M].北京:人民卫生出版社,1998.61-64.

共引文献29

同被引文献13

  • 1AI-Kouatly HB,Chasen ST,Kalish RB, et al. Causes of theombo-cytope- nia triplet gestaions [ J]. Am L Obstet Gynecol, 2003,189 ( 1 ) : 177 - 180.
  • 2Crocco I, Franchini M, Garozzo G, et al. Adverse reactionsin bloodand a- pheresis donors : experience from two Italiantransfusion centres [ J ]. Blood Transfus ,2009,7( 1 ) :35.
  • 3Moake JL, Rudy CK, Troll JH, et al. Unusually Large plasmafactor V: : yon Willebrand factormultimers in chronic relapsing throm-botic thrombo- cytopenic purpura[ J]. N Engl J Med, 1982,307 (2) : 1432.
  • 4Furlan M, Robles R, LA Mie B, et al. Partia purification andchar-acter- ization of a proteasa fi'om human plasma cleaving yon Wille-brand factor to fragments produced by invivo proteolysis [ J ]. Blood, 1996,87 ( 10 ) : 4223.
  • 5Zhou Z, jing H, Tao Z, et al. Effects of naturally occurring mutations in CUB-1 domain on synthesis,stability,and activity of ADAMTS-13 I J]. Thromb Res,2009,124 (3) :323 - 327.
  • 6Lattuada A, Rossi E, Calzarossa C, et al. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant wonmen with HELLP microangiopathic syndrome [ J ]. Haematologica, 2003,88 (9) : 1029 - 1034.
  • 7George JN. Evaluation and management of patients with thrombotic thrombocytopenic purpura [ J ]. J Intensive Care Med, 2007,22 ( 2 ) : 82 -91.
  • 8Murrin R J, Murray JA. Thrombocytopenic purprua: aetiology, pathophys- iology andtreatment[ J]. Blood Rev,2006,20( 1 ) :51.
  • 9Nikolaou M, Karakantza M, Adonakis G, et al. A case of severe AD- AMTS13 deficiency presenting as thrombotic thrombocytopenic purprua in pregnancy [ J ]. Med Pregl,2012, LXV (9/10) :436 - 439.
  • 10郑昌成,吴竞生.血栓性血小板减少性紫癜的诊治现状与进展[J].中华血液学杂志,2011,32(9):645-648. 被引量:27

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部